More Galleries
10 best cities to launch a startup Access to funding, labor and the cost of living can make or break a new business. Based on a NerdWallet study, these 10 cities are the best in the country to launch a startup. More
A $15 minimum wage is 'daunting' Seattle just passed a $15 minimum wage bill, and San Francisco will vote on one in November. It's a hot topic among lawmakers around the country, and business owners are concerned. More
From Meetup group to full-blown business When Meetup launched in 2002, its founders wanted to unite like-minded people. They never expected the site to help people launch their own businesses, but these five entrepreneurs turned their Meetup groups into profitable companies. More

Special Offer
8 of 36
Taking the sting out of canker sores
Taking the sting out of canker sores
Stephen Patterson, Patrick Gosselin, Matt Cara and Stephanie Bowen
•  enexra  video
Team name: AiB Pharma

School name: Texas A&M University, Mays Business School

Team members: Patrick Gosselin, Stephen Patterson, Matt Cara, Stephanie Bowen

Concept: Canker sores might hurt a little, but they hurt a lot of people. By one estimate, the tiny mouth ulcers make 20% of the population miserable. So far, no one has figured out what causes them or how to cure them. Available products that claim to reduce the pain and duration of the sores are often so nasty that about 80% of afflicted people choose to grimace and bear the pain without attempting treatment.

The members of AiB Pharma believe a chemical cocktail invented by Dr. Phil Campbell (who serves as an advisor to the company), a professor at the Baylor College of Dentistry, can soothe millions of mouths and make this early-stage pharmaceutical company millions of dollars. A double blind study at Baylor showed the product's efficacy to be "statistically significant," while 14 private practice dentists used the formula on more than 2,000 patients with "enormous success." The company claims the drug speeds healing by up to 86%.

Timeline: The founders of AiB Pharma believe they can have a product on the market in about four years. - Shara Rutberg

NEXT: A nanotherapy for liver cancer

Last updated May 02 2008: 11:51 AM ET
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.